Abstract We investigated the effect of chronic exposure (3 days) with low-density lipoprotein (LDL) and oxidized (Ox)-LDL on the unstimulated and stimulated formation of prostacyclin (6-keto-prostaglandin [PG]F, O ) and total inositol phosphates (IPs) by cultured bovine aortic endothelial cells. Neither basal nor bradykinin-stimulated (1 to 10 nmol/L) formation of 6-keto-PGF,,, was affected by LDL, except at the highest concentration of bradykinin tested (100 nmol/L). In the presence of the antioxidants N-acetyl-L-cysteine (NAC, 10 junol/L) or vitamin E (100 ^.mol/L), basal and bradykininstimulated formation of 6-keto-PGF, o was potentiated by 20 /ig protein/mL of LDL. Ox-LDL decreased unstimulated formation of the eicosanoid from 3.1 ±0.2 pg/jig protein in control cells to 1.6±0.1 and 0.5±0.1 pg/^g protein after 3-day incubation with 5 and 20 /xg protein/mL of Ox-LDL, respectively (P<.05). As in the basal state, Ox-LDL decreased F or many years, it was accepted that injury to the endothelium triggered the atherosclerotic lesion, but studies in a number of laboratories show that fatty-streak lesions can and do develop under an intact endothelial layer. Circulating monocytes penetrate between endothelial cells, enter the intima, and there become loaded with lipoprotein-derived lipids.
F or many years, it was accepted that injury to the endothelium triggered the atherosclerotic lesion, but studies in a number of laboratories show that fatty-streak lesions can and do develop under an intact endothelial layer. Circulating monocytes penetrate between endothelial cells, enter the intima, and there become loaded with lipoprotein-derived lipids.
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The low-density lipoproteins (LDLs) have to undergo oxidative modification (Ox-LDL) to be taken up by macrophages. 3 One may postulate that LDL uptake serves a protective function, preventing endothelial damage that otherwise might cause thrombosis even sooner. However, Ox-LDL can be highly cytotoxic. Antioxidant therapy in an animal model of hypercholesterolemia prevents the formation of fatty streaks, demonstrating that the oxidative modification of LDL gives it an atherogenic role. 4 Once the macrophages in the artery are heavily loaded with lipids, they may possibly become nonfunctional or die, releasing their contents. Ox-LDL, through its cytotoxicity, may then cause injury to the endothelial cells overlying the fatty streak. 5 What part, then, does endothelial injury play? Could Ox-LDL have a role in the progression of the fatty-streak lesion to a more complicated lesion? One attractive hypothesis is that Ox-LDL could first inter-fere with the cellular protective mechanism and thereby accelerate the progression of the atherosclerotic lesion by increasing monocyte adhesion and cellular proliferation.
Prostacyclin, an arachidonic acid (AA)-derived product, is a potent cytoprotective agent, inhibiting cell proliferation, platelet adhesion and aggregation, and monocyte adhesion. 6 Its release from cultured endothelial cells, which seems to be dependent on formation of inositol phosphates (IPs), 7 can be stimulated by low concentrations of hydrogen peroxide 8 or short-term exposure to Ox-LDL. 9 Potentially, even the cell's own oxidative metabolism could be a stimulus. However, the production of prostacyclin is decreased in atherosclerotic tissues and smooth muscle cells from atheromatous lesions in culture. 10 -' 3 The observation that high concentrations of hydrogen peroxide can also alter the production of prostacyclin by endothelial cells 8 suggests that chronic exposure with pro-oxidative reactive species like Ox-LDL could alter the endothelial AA pathway and thereby, the endothelial protective function.
In this study, we used bovine aortic endothelial cells in culture to investigate the effect of chronic exposure to LDL and Ox-LDL on the unstimulated and stimulated release of prostacyclin. The results obtained demonstrate that, at a very low concentration, Ox-LDL inhibits eicosanoid release without affecting the formation of IPs. Part of these results have been presented to the British Pharmacological Society. aorta was flushed with sterile saline (containing gentamicin [500 tig/mL], penicillin [100 U/mL], and streptomycin [100 tig/mL]), tied off at one end, and cannulated at the other with a 60-mL syringe containing sterile saline solution at ambient temperature. Saline was infused into the lumen before the vessel was transported to the laboratory within 30 minutes. The endothelial cells were then isolated by enzymatic digestion. After the intercostal arteries were ligated, the aorta was washed with sterile saline, and 10 mL of collagenase solution (1%, type II, Sigma) in Dulbecco's modified Eagle medium (DMEM) was introduced into the aortic lumen. The vessel was then incubated at 37°C for 20 minutes. The collagenase solution was collected in a sterile tube, and remaining cells were harvested with 10 mL of sterile saline. Cells were spun down for 5 minutes at 700 rpm and 10°C. The supernatant was discarded, and the cells were resuspended in DMEM supplemented with fetal calf serum and newborn calf serum (10%, vol/vol), gJutamine (2 mmol/L), penicillin (100 U/mL), streptomycin (100 /xg/mL), and gentamicin (500 ttg/mL). After another centrifugation under the aforementioned conditions, the medium was discarded, and the cells were resuspended in 10 mL of supplemented DMEM. The cells were then seeded into a 75-mL culture flask (NUNC) and grown to confluence. The culture medium was replaced every day, and cells were used within 4 to 10 days.
At confluence, cells were harvested from the culture flask with trypsin-EDTA solution (0.25% in Puck's saline). The reaction was stopped with 10 mL supplemented DMEM. Cells were counted with a hematocytometer slide, and 10 3 cells/mL supplemented DMEM were seeded in 1-mL 24-well plates. After 24 hours, cells were confluent, and supplemented DMEM was replaced with medium 199 (M199) supplemented with penicillin (100 U/mL), streptomycin (100 /xg/mL), and gentamicin (500 /xg/mL). After 24 hours, supplemented M199 was replaced with fresh supplemented M199 for another 18-hour period. All tissue culture media and supplements were obtained from GIBCO BRL.
Measurement of Prostacyclin
Before experimentation, the tissue culture medium was removed by aspiration, and the cells were washed with2xlmL Krebs carbonate solution containing (mmol/L) NaCl 118, KC1 4.7, MgCI 2 1.2, NaH 2 PO 4 1, CaCl 2 2.6, NaHCO 3 25, glucose 11.1, and EDTA 0.03, pH 7.4, and incubated in 1 mL Krebs solution at 37°C under an atmosphere of 95% O 2 /5% CO 2 for 1 hour. After this time, the Krebs solution was removed and replaced with either 0.5 mL normal Krebs solution or Krebs solution containing bradykinin (1 to 100 nmol/L), ATP (1 mmol/L), or AA (0.01 and 1 timol/L) and incubated for 30 minutes. The Krebs solution was retained for analysis of prostacyclin and stored at -70°C for a maximum of 2 weeks. The prostacyclin content of the Krebs solution was determined by radioimmunoassay (measured as 6-keto-prostaglandin [PG]F )a ) with a commercially available kit (Amersham). Prostacyclin production is expressed as picograms 6-keto-PGF, a per microgram protein. The protein content of each well was measured by the technique of Lowry et al. 15 
Measurement of Phosphoinositide Hydrolysis
The hydrolysis of phosphoinositides was measured as the accumulation of total IPs in the presence of lithium chloride. Eighteen hours before the experiment, supplemented M199 was replaced with supplemented M199 containing 0.5 /xCi/mL m>w-[ 3 H]inositol. After this incubation, the labeled medium was aspirated, and the cells were washed with 2x1 mL of the following buffer at 3 7^ (mmol/L): NaCl 133, KC1 3.6, MgCl 2 0.4, glucose 16, and HEPES buffer 3, pH 7.4. Cells were then incubated for 10 minutes in 1 mL buffer containing 10 mmol/L LiCl and for a further 30 minutes with or without bradykinin (100 nmol/L, 10 ttmol/L) in buffer containing lithium chloride. After this stimulation period, the buffer was removed by aspiration, and the stimulation was stopped by addition of 100 /xL of 10% perchloric acid to the cells. The cells were scraped and aspirated from the well and placed in an Eppendorf vial. Five hundred microliters of distilled water was added and the sample centrifuged at 13 000 rpm for 5 minutes. Five hundred microliters of the supernatant was removed to a tube containing 130 fiL of 10 mmol/L EDTA (pH 7.0) for measurement of total IPs. The remainder of the sample in the Eppendorf vial was stored at 4°C for total phosphatidylinositol analysis. Three hundred sixty microliters of 1:1 (vol/vol) freon/tri-n-octylamine was added, and samples were vortexed and centrifuged at lOOOg for 4 minutes. Five hundred microliters of the aqueous phase was carefully removed to a tube containing 1 mL 5 mmol/L sodium tetraborate in 0.5 mmol/L EDTA (pH 6.7). The samples were run through columns composed of Dowex ion exchange resin in the formate form. Columns were washed with 15 mL of 5 mmol/L unlabeled myo-inositol. Finally, 1.5 mL of 1 mmol/L ammonium formate in 0.1 mmol/L formic acid (pH 4.0) was run through each column and the eluate, containing the total [ 3 H]IPs, was collected in a glass scintillation vial. Scintillant was added, and the samples were counted on a liquid scintillation counter.
After the procedure described above, to each sample kept for phosphatidylinositol analysis, 470 /xL chloroform/methanol/hydrochloric acid (40:80:1, vol/vol/vol) was added, and samples were vortexed and left overnight at 4°C. Three hundred ten microliters chloroform/distilled water (1:1, vol/vol) was then added, and samples were centrifuged for 10 minutes at 100Qt>. Two hundred fifty microliters of the chloroform phase was removed to a glass scintillation vial and left to evaporate. Scintillant was added, and samples were counted in a liquid scintillation counter. Total IPs are expressed as a percent of total [ 
Preparation of LDL and Oxidation
Human LDL was isolated from freshly drawn blood from healthy, normolipidemic, fasting volunteers in the presence of tripotassium EDTA by sequential density-gradient ultracentrifugation in the density range 1.019 to 1.063 g/mL. The isolated LDL was filtered (0.45-ttm membrane) and dialyzed to remove EDTA. LDL was stored at a concentration of 200 tig protein/mL in the dark in phosphate-buffered saline (PBS) free of transition metals and containing 1 mg/mL EDTA (after a 10 times dilution, the concentration of EDTA was too low to have antioxidant properties 16 ). Copper-mediated oxidation was achieved by incubating LDL (200 tig protein/mL) in PBS with a sterile solution of CuC1 2 (final concentration of 10 timol/L) at room temperature for 12 hours. LDL preparations were filtered (0.22-ttm membrane) before addition to the cell medium and used within 3 weeks of isolation.
Quantification of Lipid Oxidation
Oxidation of LDL lipids was estimated by assaying for thiobarbituric acid-reactive substances (TBARS) by the fluorometric method of Ohkawa et al. 17 Briefly, to 50 tig LDL protein (0-5 mg/mL) or 0.5 mL culture medium, 1.5 mL acetic acid (20%, pH 3.5) and 15 mL freshly dissolved solution (0.8%) of thiobarbituric acid were added, and the mixture was boiled for 1 hour, cooled with running water, mixed with 2.5 mL butan-1-ol, and cleared by centrifugation. Fluorometric measurements were made at 553 nm with 515-nm excitation. The amount of TBARS was determined against a standard curve obtained with freshly diluted 1,1,3,3-tetramethoxypropane.
Cytotoxicity Studies
Cytotoxicity studies were performed on days 5 (confluent cells) and 7 (after 2 days in M199) by use of cell count analysis and vital dye exclusion (trypan blue, 0.05%).
Protocols
The bovine aortic endothelial cells were incubated for 3 days without or with LDL or Ox-LDL at a concentration of 5 or 20 jig protein/mL. In the control group of cells, PBS was added to the culture medium. The antioxidants N-acetyl-L-cysteine (NAC, 10 jimol/L final concentration, Sigma) or vitamin E (100 Aimol/L final concentration, Sigma) were added to the cells for the 3 days of incubation with PBS, LDL, or Ox-LDL.
Statistical Analysis
Results are expressed as the mean±SEM, and comparisons were made by one-way ANOVA, followed by a Student's / test analysis. In the case of nonparametric distribution of the data, results are expressed as median and range, and the comparisons between groups were done by the Kruskal-Wallis test. Differences among means or medians were considered significant at F<.05.
Results

Cytotoxicity Assays
The growth rate of endothelial cells was not affected by Ox-LDL at a concentration of 20 /ig protein/mL. After a 5-day incubation period, cells reached confluence in both Ox-LDL-treated cells and PBS-treated control cells. 
Total Protein Content
Three days of incubation of endothelial cells with 5 fig protein/mL LDL (n=24) had no effect on total protein content (59±3 jig/well) compared with control (58 ±2 /xg/well) but increased slightly in the presence of 5 pig protein/mL Ox-LDL (70±2 fig/we\\ , F<.05 versus control and LDL groups).
In seven independent experiments, 3 days of incubation of endothelial cells with 20 ^.g protein/mL LDL did not affect the protein content of the wells compared with control but was significantly decreased, by 45 ±7%, by 20 ng protein/mL Ox-LDL compared with control. Protein contents per well (in micrograms) were, in the control groups, (1) 99±2 (n=40), (2) 113±3 (n = 18), (3) 146+12 (n=6), (4) 51±8 (n=36), (5) 48±2 (n=24), (6) 31±1 (n = 12), and (7) 48±2 (n=24); in the LDL groups (20 /ig/mL), (1) 92±2, (2) 99±2, (3) 127±10, (4) 51 ±6, (5) 51±1, (6) 28±1, and (7) 51±1; and in the Ox-LDL groups, (1) 73±3, (2) 67±8, (3) 106±6, (4) 16±6, (5) 22±1, (6) 23 + 1, and (7) 23±1 /ig/well, all the values obtained in the presence of Ox-LDL being significantly lower compared with control (P<.05).
The antioxidant NAC (10 fimo\/L) had no influence on the protein content in the presence or absence of the lipoproteins at either concentration tested (data not shown). Vitamin E (100 /imol/L, n = 12) significantly increased the protein content in each group of treated cells and suppressed the significant inhibitory effect of Ox-LDL on the protein level: in the absence of vitamin E, protein contents were 31 ±1,28±1, and 23±1 /xg/well in PBS-, LDL-, and Ox-LDL-treated cells, respectively. In the presence of the antioxidant, the amounts of protein were 37±1, 33±1, and 41 ±1 ^g/well, respectively (P<.05 compared with the results obtained in the absence of vitamin E).
Oxidation of LDL
The TBARS values for native LDL preparations were below the sensitivity of the assay, whereas the mean value for Ox-LDL preparations was 9.6±0.3 nmol/mg.
The incubation medium being changed every day, the TBARS value of the medium containing PBS, LDL, or Ox-LDL was measured after 18 hours of incubation with or without endothelial cells (n=7 independent experiments per group). The medium by itself, with or without 20 fig LDL protein/mL, had no TBARS value.
After an 18-hour incubation period without cells, 19 ±4% of LDL was spontaneously oxidized. This value was not affected by NAC (20±5%).
In the presence of cells, 66±5% of LDL was oxidized. When NAC (10 /xmol/L) was added to the medium, however, only 36 ±2% of LDL was oxidatively modified (P<.05). The cell-dependent oxidative process represents 46 ±2% of LDL oxidation (total minus spontaneous oxidation), an effect that was reduced by 63% by the antioxidant to represent only 16±3% of LDL being oxidatively modified by the endothelial cells (P<.05).
Unstimulated Release of Prostacyclin
Basal formation of 6-keto-PGF la was not affected by 3 days of incubation of the endothelial cells with 5 or 20 Atg/mL LDL protein (Tables 1 and 2 ). Oxidized LDL decreased the basal formation of 6-keto-PGF, 0 by >50% and 80% at 5 and 20 pig/mL, respectively (Tables  1 and 2 ). NAC had no effect on the unstimulated formation of prostacyclin in cells incubated with 5 [ig/mL LDL protein, but both NAC and vitamin E increased the basal formation of 6-keto-PGF,,, in the presence of 20 ^.g/mL LDL protein (Tables 1 and 2 ). Both antioxidants had no influence in Ox-LDL groups (Tables 1 and 2) . A short incubation period of 1 hour with either LDL or Ox-LDL (20 ^g protein/mL) did not affect the basal formation of 6-keto-PGF, 0 (4.2±0.2 and 3.8±0.3 pg//ig protein) compared with PBS-treated cells (4.1±0.5 pg/^g protein).
Stimulated Release of Prostacyclin
Bradykinin dose-dependently stimulated the release of prostacyclin by endothelial cells. Added to the culture medium, the antioxidant NAC (10 j/.mol/L) decreased the stimulated formation of 6-keto-PGF la at the highest concentration of bradykinin tested (100 nmol/L) from 43.9±3.1 to 30.6±2.4 pg//xg protein (P<.05), whereas vitamin E (100 fimolfL) had no significant effect on bradykinin-induced prostacyclin release (Table 2) (Table 2) . During bradykinin stimulation, the inhibitory effect of LDL was reversed by NAC (Figure, B) , whereas vitamin E suppressed the inhibitory effect of LDL on 100 nmol/L bradykinin-induced 6-keto-PGF, 0 formation ( Table 2) .
Incubation of the cells with Ox-LDL inhibited bradykinin-induced prostacyclin release (Figure, C) . At the higher concentration of Ox-LDL tested (20 /xg/mL), the stimulated formation of 6-keto-PGF,,, was abolished. The antioxidants NAC (Figure, D) and vitamin E ( Table 2) had no influence on the inhibitory effect of oxidized lipoprotein on bradykinin-induced prostacyclin release.
The effects of the lipoproteins at a concentration of 20 fig protein/mL were also investigated on ATP-and AA-induced 6-keto-PGF, o formation. The stimulated release of prostacyclin by ATP (1 mmol/L) or AA (0.01 and 1 /xmol/L) was potentiated by LDL after 3 days of incubation with endothelial cells by 100% or 120% and 58%, respectively (Table 3) . After 3 days of incubation with Ox-LDL, ATP-induced 6-keto-PGF lQ formation was decreased by >95%, as previously observed with bradykinin. However, the stimulated release of prostacyclin induced by AA was not altered for the lower concentration tested (0.01 ^.mol/L) but decreased by >75% for the higher (1 /xmol/L) concentration (Table 3) .
Phosphoinositide Hydrolysis
IPs may be involved in prostacyclin release. We investigated the effect of the higher concentration of lipoproteins on total IPs formation. The technique used being less sensitive than the radioimmunoassay of 6-keto-PGF lo , a bradykinin concentration of 100 nmol/L to 10 /Limol/L was used to reach a maximum stimulation of IPs formation.
Basal formation of total [ (Table 4) . When stimulated with bradykinin, the resulting total IPs formation remained increased for the lowest concentration of agonist (100 nmol/L) but not significantly altered by LDL or Ox-LDL for the highest (10 /xmol/L) concentration of bradykinin tested compared with control (Table 4) .
In another series of experiments (n=8 per group), the effect of NAC (10 /xmol/L) on basal IPs production was studied. As reported above, native LDL and Ox-LDL stimulated the basal formation of IPs (7.4±0.2% and 10.8±1.4% of total PI, respectively, P<.05) compared with control (6.1 ±0.3% of total PI). Basal IPs production was not significantly affected by NAC in control cells (7.1 ±0.5% of total PI). Treatment with the antioxidant also had no effect in LDLtreated cells (8.4±0.5% of total PI), but it was no longer significantly different from the NAC-treated control group (P=.101). Finally, basal IPs formation remained significantly increased in Ox-LDL-treated cells when incubated with NAC (10.5±1.2% of total PI, P<.05 compared with NAC-treated control cells).
Discussion
This study suggests that Ox-LDL can inhibit prostacyclin release from cultured endothelial cells. The atherogenicity of Ox-LDL is now accepted as being one of the key events in the formation of the fatty streak. dation of LDL has been demonstrated in vitro in cultured endothelial cells. Therefore, experiments with LDL were carried out in the absence or presence of an antioxidant. NAC (10 jtmol/L) was chosen because we have shown it to inhibit LDL oxidation in plasma ex vivo. 19 Some experiments were carried out in the presence of vitamin E, an endogenous antioxidant. 20 LDL had no effect on basal prostacyclin production when alone but increased production in the presence of antioxidant. Bradykinin-stimulated production was also modified by NAC and vitamin E in the presence of LDL. Bradykinin-induced 6-keto-PGFi 0 formation was slightly decreased by LDL, whereas in the presence of antioxidants, the stimulated production of prostacyclin rose. These effects of the antioxidants in the presence of the higher concentration of LDL tested (20 ^.g/mL) suggest that an endothelium-dependent oxidative mechanism does occur in our experimental system. This hypothesis is confirmed by the increase in TBARS value in the medium of LDL-treated cells, an effect partially reversed by NAC, as previously described by others. 18 In contrast to bradykinin-stimulated 6-keto-PGF lCT formation, the facilitatory effect of LDL on ATPinduced 6-keto-PGF, Q formation occurred in the absence of NAC. A recent study shows that, in contrast to thrombin (another agonist inducing prostacyclin release), ATP-induced 6-keto-PGF la formation can be abolished by activation of protein kinase C. 7 Different regulatory mechanisms of the prostacyclin synthetic pathway could account for the difference of effect of LDL observed during different receptor-dependent prostacyclin release mechanisms. 21 Another explanation for this result could be an increase in AA available because of the lipoprotein stimulating the cyclooxygen- ase/prostacyclin synthase pathway. 9 However, the mechanism by which LDL stimulates prostacyclin formation is not clear.
The receptor-mediated release of prostacyclin is coupled to phospholipase C activation. 7 Under basal conditions, LDL stimulated phospholipase C activity, an effect that was not mediated by a cell-dependent oxidative process of LDL. The maximum stimulation of IPs production was not affected by LDL, but for a concentration of 100 nmol/L, bradykinin-induced IPs formation remained significantly higher, revealing a dissociation between the release of prostacyclin (which decreased) and the enhanced activity of the phospholipase C. The physiological significance of this dissociation between the signal transduction mechanism and the biological response is difficult to explain. The decrease in the biological response can be reversed by antioxidant treatment, whereas phospholipase C activity was not sensitive to antioxidants. The rise in phospholipase C activity in the presence of LDL (as well as Ox-LDL) could represent an attempt by the cells to compensate for the decrease in prostacyclin release. The existence of such a feedback mechanism has yet to be demonstrated.
The effect of Ox-LDL on 6-keto-PGF lo formation by endothelial cells was more dramatic. In the presence of oxidized lipoprotein, unstimulated formation of prostacyclin was decreased at the lower concentration of Ox-LDL tested (5 /xg/mL) and almost abolished at the higher (20 Mg/mL). The chronic effect of Ox-LDL is different from the effect of acute exposure to endothelial cells, which has been shown to stimulate the release of prostacyclin. 9 This was attributed to a manifestation of an early response to injury. During the atherosclerotic process, however, Ox-LDL is probably chronically in contact with the endothelial layer. Previous work showed that prostacyclin release is selectively decreased at the level of the atherosclerotic lesion compared with the surrounding area 12 as well as in smooth muscle cells isolated from atherosclerotic rabbit aorta, in which cyclooxygenase and prostacyclin synthase activities appear to be reduced. 10 The mechanism for the decrease in prostacyclin is unknown, but three lines of evidence support an oxidation-dependent alteration. First, antioxidant treatment reversed the inhibitory effect of LDL on prostacyclin release but had no effect on the Ox-LDL-induced decrease in unstimulated 6-keto-PGF, O formation. Second, Taylor et al 8 demonstrated that a low concentration of hydrogen peroxide stimulated the release of prostacyclin, whereas a higher concentration antagonized it. Finally, it has been shown that lipid peroxides resulting from lipid accumulation in atherosclerosis destroyed the prostacyclin synthase by oxidative deactivation. 22 Taken together, all these elements suggest that Ox-LDL itself could trigger the decrease in prostacyclin synthesis observed in atherosclerotic lesions. 12 As well as inhibiting basal formation of prostacyclin, Ox-LDL chronically incubated with endothelial cells almost abolished the receptor-dependent stimulated release of prostacyclin, suggesting that the alteration is not specific for one class of receptor. Moreover, AAinduced 6-keto-PGF, a formation did not appear to be dose-dependently related. Those two latter observations, in conjunction with the absence of modification of phospholipase C maximum activity, suggest that the Ox-LDL-induced decrease in prostacyclin release may be related to a decrease in enzyme activities and/or quantities within the cells rather than a receptor-dependent alteration.
High concentrations of oxidized lipoprotein can be cytotoxic. 20 The higher concentration of Ox-LDL used in this study (20 ^ig/mL) decreased the total amount of protein. This effect, however, cannot explain the decrease in prostacyclin release observed at the lower concentration of Ox-LDL or at the higher concentration in the presence of vitamin E, since this phenomenon still occurred despite a significant increase or a normalization in the protein content per well, respectively. The stimulated phospholipase C activity, moreover, was not altered after 3 days of incubation with 20 ixg/mL Ox-LDL, nor was cell number or cell viability. At the concentration used, Ox-LDL appears not to be cytotoxic.
In conclusion, the data presented here indicate that endothelial cells chronically exposed to Ox-LDL have a severely impaired capacity to release prostacyclin. Such interference with AA utilization in aortic endothelial cells may be involved in the progression of the fatty streak to a more advanced atherosclerotic lesion.
